Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1127789

Cover Image

PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1127789

GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

PUBLISHED:
PAGES: 112 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 2699
PDF (5 User License)
USD 3699
PDF (Corporate License)
USD 4699

Add to Cart

The GCC generic injectables market size reached US$ 525.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,199.7 Million by 2027, exhibiting a growth rate (CAGR) of 15.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases and osteoporosis. A rise in the prevalence of various lifestyle diseases in the GCC region has catalyzed the demand for these injectables. The lower cost of these drugs as compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.

Market Drivers:

  • An increase in the emigrant population along with a rise in the cases of both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The resulting surge in the overall healthcare costs has boosted the demand for these injectables. Moreover, upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers. Apart from this, the total number of manufacturers in the market is lower as compared to those in the oral generics segment. This results in lower price erosion and significantly higher margins. Some of the other factors driving the market in this region include aging population, development of the private healthcare sector and improving standards of living.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the GCC generic injectables market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on container type, therapeutic area and distribution channel.

Breakup by Container Type:

  • Vials
  • Prefilled Syringes
  • Ampoules
  • Premix
  • Others
  • Vials account for the majority of the total market as they are compact in size, can be reused and are graduated with markings.

Breakup by Therapeutic Area:

  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Cardiovascular
  • Parenteral Nutrition
  • Others
  • Currently, oncology represents the most popular therapeutic area on account of a rise in cancer diagnosis coupled with improved access to treatment.

Breakup by Distribution Channel:

  • Hospitals
  • Clinics
  • Retail Pharmacy Stores
  • These injectables are majorly distributed through hospitals as they cannot be traded or administered without medical assistance.

Regional Insights:

  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman
  • Bahrain
  • Saudi Arabia represents the leading market within the region. The manufacturers in the country are consistently collaborating with key pharma players for expanding their production capacity.

Competitive Landscape:

  • The competitive landscape of the market has also been analyzed in the report along with the profiles of key players.

Key Questions Answered in This Report:

  • How has the GCC generic injectables market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the GCC generic injectables industry?
  • What has been the impact of COVID-19 on the GCC generic injectables market?
  • What are the several therapeutic areas in the GCC generic injectables industry?
  • What are the major distribution channels in the GCC generic injectables industry?
  • What are the different container types in the GCC generic injectables industry?
  • What are the various stages in the value chain of the GCC generic injectables industry?
  • What are the key driving factors and challenges in the GCC generic injectables industry?
  • What is the structure of the GCC generic injectables industry and who are the key players?
  • What is the degree of competition in the GCC generic injectables industry?
  • What are the profit margins in the GCC generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
Product Code: SR1022A58_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 GCC Generic Injectables Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Region
  • 5.5 Market Breakup by Therapeutic Area
  • 5.6 Market Breakup by Container Type
  • 5.7 Market Breakup by Distribution Channel
  • 5.8 Market Forecast
  • 5.9 SWOT Analysis
    • 5.9.1 Overview
    • 5.9.2 Strengths
    • 5.9.3 Weaknesses
    • 5.9.4 Opportunities
    • 5.9.5 Threats
  • 5.10 Value Chain Analysis
    • 5.10.1 Research and Development
    • 5.10.2 Manufacturing
    • 5.10.3 Marketing and Distribution
  • 5.11 Porter's Five Forces Analysis
    • 5.11.1 Overview
    • 5.11.2 Bargaining Power of Supplier
    • 5.11.3 Bargaining Power of Buyers
    • 5.11.4 Degree of Competition
    • 5.11.5 Threat of New Entrants
    • 5.11.6 Threat of Substitutes
  • 5.12 Price Analysis
    • 5.12.1 Key Price Indicators
    • 5.12.2 Price Structure
    • 5.12.3 Margin Analysis
  • 5.13 Key Market Drivers and Success Factors

6 Market Performance by Key Regions

  • 6.1 Saudi Arabia
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 UAE
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Kuwait
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Qatar
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Oman
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Bahrain
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Performance by Container Type

  • 7.1 Vials
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prefilled Syringes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ampoules
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Premix
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Performance by Therapeutic Area

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Anaesthesia
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Anti-infectives
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cardiovascular
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Parenteral Nutrition
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Performance by Distribution Channel

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacy Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Competitive Landscape

  • 10.1 Competitive Structure
  • 10.2 Key Players

11 Generic Injectable Manufacturing Process

  • 11.1 Product Overview
  • 11.2 Detailed Process Flow
  • 11.3 Various Types of Unit Operations Involved
  • 11.4 Mass Balance and Raw Material Requirements

12 Project Details, Requirements and Costs Involved

  • 12.1 Land, Location and Site Development
  • 12.2 Construction Requirements
  • 12.3 Machinery Requirements
  • 12.4 Machinery Pictures
  • 12.5 Raw Material Requirements
  • 12.6 Raw Material and Final Product Pictures
  • 12.7 Packaging Requirements
  • 12.8 Transportation Requirements
  • 12.9 Utility Requirements
  • 12.10 Manpower Requirements
  • 12.11 Other Capital Investments

13 Key Player Profiles

Product Code: SR1022A58_Report

List of Figures

  • Figure 1: GCC: Generic Injectables Market: Major Drivers and Challenges
  • Figure 2: GCC: Generic Injectables Market: Sales Value (in Million US$), 2016-2021
  • Figure 3: GCC: Generic Injectables Market: Breakup by Region (in %), 2021
  • Figure 4: GCC: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2021
  • Figure 5: GCC: Generic Injectables Market: Breakup by Container Type (in %), 2021
  • Figure 6: GCC: Generic Injectables Market: Breakup by Distribution Channel (in %), 2021
  • Figure 7: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 8: GCC: Generic Injectables Industry: SWOT Analysis
  • Figure 9: GCC: Generic Injectables Industry: Value Chain Analysis
  • Figure 10: GCC: Generic Injectables Industry: Porter's Five Forces Analysis
  • Figure 11: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 12: Saudi Arabia: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 13: UAE: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 14: UAE: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 15: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 16: Kuwait: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 18: Qatar: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 19: Oman: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 20: Oman: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 21: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 22: Bahrain: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 23: GCC: Generic Injectables (in Vials) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 24: GCC: Generic Injectables (in Vials) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 25: GCC: Generic Injectables (in Prefilled Syringes) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 26: GCC: Generic Injectables (in Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 27: GCC: Generic Injectables (in Ampoules) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 28: GCC: Generic Injectables (in Ampoules) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 29: GCC: Generic Injectables (in Premix) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 30: GCC: Generic Injectables (in Premix) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 31: GCC: Generic Injectables (in Other Container Types) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 32: GCC: Generic Injectables (in Other Container Types) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 33: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 34: GCC: Generic Injectables (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 35: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 36: GCC: Generic Injectables (Anaesthesia) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 37: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 38: GCC: Generic Injectables (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 39: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 40: GCC: Generic Injectables (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 41: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 42: GCC: Generic Injectables (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 43: GCC: Other Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 44: GCC: Other Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 45: GCC: Generic Injectables Market: Sales through Hospitals (in Million US$), 2016 & 2021
  • Figure 46: GCC: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2022-2027
  • Figure 47: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2016 & 2021
  • Figure 48: GCC: Generic Injectables Market Forecast: Sales through Clinics (in Million US$), 2022-2027
  • Figure 49: GCC: Generic Injectables Market: Sales through Retail Pharmacy Stores (in Million US$), 2016 & 2021
  • Figure 50: GCC: Generic Injectables Market Forecast: Sales through Retail Pharmacy Stores (in Million US$), 2022-2027
  • Figure 51: Generic Injectables Manufacturing: Detailed Process Flow
  • Figure 52: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 53: Generic Oncology Drug Manufacturing Plant: Tertiary Packaging
  • Figure 54: Generic Injectables Manufacturing Process: Breakup of Capital Costs (in %)
  • Figure 55: Generic Injectables Industry: Breakup of Profit Margins at Various Level of the Value Chain

List of Tables

  • Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2021 and 2027
  • Table 2: GCC: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 3: GCC: Generic Injectables Market Forecast: Breakup by Container Type (in Million US$), 2022-2027
  • Table 4: GCC: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
  • Table 5: GCC: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
  • Table 6: GCC: Generic Injectables Industry: Competitive Structure
  • Table 7: GCC: Generic Injectables Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!